Abstract
The incidence of small renal masses (SRM) is increasing in recent years due to more frequent use of abdominal imaging, consequentially conferring higher costs on the health system. As costs increase, financial considerations will have a significant impact on the availability of treatments and technologies. Recognizing and understanding these considerations is important for the treating physician. In this chapter, we will explain the basic terminology and concepts of cost analysis and provide a review of current literature assessing the cost of several treatment options for the management of SRMs including surveillance, the use of biopsies to guide treatment, and different ablative and surgical techniques.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Keehan SP, Stone DA, Poisal JA, Cuckler GA, Sisko AM, Smith SD, et al. National health expenditure projections, 2016–25: price increases, aging push sector to 20 percent of economy. Health Aff. 2017;36(3):553–63.
Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: A trend analysis. Eur Urol. 2011;59(1):135–41.
Richard PO, Jewett MAS, Bhatt JR, Kachura JR, Evans AJ, Zlotta AR, et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol. 2015;68(6):1007–13.
Johnson DC, Vukina J, Smith AB, Meyer A-M, Wheeler SB, Kuo T-M, et al. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol. 2015;193(1):30–5.
Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198(3):520–9.
Lotan Y, Cadeddu JA. A cost comparison of nephron-sparing surgical techniques for renal tumour. BJU Int. 2005;95(7):1039–42.
Lotan Y, Haddad AQ, Costa DN, Pedrosa I, Rofsky NM, Roehrborn CG. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. Urol Oncol. 2015;33(6):266.e9–e16.
Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. J Urol. 2011;185(5):1591–7.
Lotan Y, A Cadeddu J, T Gettman M. The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol. 2004;172(4 Pt 1):1431–5.
Lotan Y, Cadeddu JA, Pearle MS. International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res. 2005;33(3):223–30.
Svatek RS, Lotan Y. Cost utility of prostate cancer chemoprevention with dutasteride in men with an elevated prostate specific antigen. Cancer Prev Res. 2011;4(2):277.
Lotan Y, Duchene DA, Cadeddu JA, Koeneman KS. Cost comparison of hand assisted laparoscopic nephrectomy and open nephrectomy: analysis of individual parameters. J Urol. 2003;170(3):752–5.
Lotan Y, Gettman MT, Roehrborn CG, Pearle MS, Cadeddu JA. Cost comparison for laparoscopic nephrectomy and open nephrectomy: analysis of individual parameters. Urology. 2002;59(6):821–5.
Mir SA, Cadeddu JA, Sleeper JP, Lotan Y. Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol. 2011;25(3):447–53.
Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016;69(4):660–73.
Pandharipande PV, Gervais DA, Hartman RI, Harisinghani MG, Feldman AS, Mueller PR, et al. Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology. 2010;256(3):836–46.
Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, Iyoha E, et al. Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol. 2016;196(4):989–99.
Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol. 2016;195(5):1340–7.
Dutta R, Okhunov Z, Vernez SL, Kaler K, Gulati AT, Youssef RF, et al. Cost comparisons between different techniques of percutaneous renal biopsy for small renal masses. J Endourol. 2016;30(Suppl 1):S28–33.
Heilbrun ME, Yu J, Smith KJ, Dechet CB, Zagoria RJ, Roberts MS. The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a Markov model. J Urol. 2012;187(1):39–43.
Castle SM, Gorbatiy V, Avallone MA, Eldefrawy A, Caulton DE, Leveillee RJ. Cost comparison of nephron-sparing treatments for cT1a renal masses. Urol Oncol. 2013;31(7):1327–32.
Alemozaffar M, Chang SL, Kacker R, Sun M, DeWolf WC, Wagner AA. Comparing costs of robotic, laparoscopic, and open partial nephrectomy. J Endourol. 2013;27(5):560–5.
Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology. 2008;248(1):169–78.
Lotan Y. The future of nephron sparing procedures for renal masses: balancing costs, efficacy, patient outcomes and experience. J Urol. 2011;185(5):1560–1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Freifeld, Y., Lotan, Y. (2020). Financial Considerations in the Management of Small Renal Masses. In: Leveillee, R., Jorda, M. (eds) Renal Mass Biopsy. Springer, Cham. https://doi.org/10.1007/978-3-030-36036-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-36036-8_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36035-1
Online ISBN: 978-3-030-36036-8
eBook Packages: MedicineMedicine (R0)